» Articles » PMID: 39193540

Adoption of a Societal Perspective in Economic Evaluations of Musculoskeletal Disorders: A Conceptual Paper

Overview
Publisher MDPI
Specialty Public Health
Date 2024 Aug 28
PMID 39193540
Authors
Affiliations
Soon will be listed here.
Abstract

Economic evaluations are used to compare the costs and consequences of healthcare interventions, including those for musculoskeletal (MSK) disorders, which are very common and a major source of morbidity and absence from work. Reimbursement decisions for interventions for MSK disorders by decision-makers rely on the findings of economic evaluations, the design and results of which depend largely on the perspective adopted. Despite methodological advancements in economic evaluations, there are no clear guidelines on the perspective to adopt. This paper explores the adoption of a societal perspective in economic evaluations of MSK disorders. Within health economics evaluations, the most commonly used perspectives include the payer perspective, the healthcare perspective, and the societal perspective. To facilitate optimal resource allocation decisions in order to reduce the significant economic burden of MSK disorders and improve the health outcomes of individuals with these disorders, all costs and benefits associated with interventions for them should be included. Thus, the societal perspective is arguably a preferable option to the others for economic evaluations of interventions for MSK disorders.

References
1.
Burgess R, Hall J, Bishop A, Lewis M, Hill J . Costing Methodology and Key Drivers of Health Care Costs Within Economic Analyses in Musculoskeletal Community and Primary Care Services: A Systematic Review of the Literature. J Prim Care Community Health. 2020; 11:2150132719899763. PMC: 6966248. DOI: 10.1177/2150132719899763. View

2.
Shahrezaee M, Keshtkari S, Moradi-Lakeh M, Abbasifard M, Alipour V, Amini S . Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017. Arch Osteoporos. 2020; 15(1):103. DOI: 10.1007/s11657-020-00767-8. View

3.
Gallego G, Casey R, Norman R, Goodall S . Introduction and uptake of new medical technologies in the Australian health care system: a qualitative study. Health Policy. 2011; 102(2-3):152-8. DOI: 10.1016/j.healthpol.2011.04.003. View

4.
Sebbag E, Felten R, Sagez F, Sibilia J, Devilliers H, Arnaud L . The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database. Ann Rheum Dis. 2019; 78(6):844-848. DOI: 10.1136/annrheumdis-2019-215142. View

5.
Hsieh P, Wu O, Geue C, McIntosh E, McInnes I, Siebert S . Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Ann Rheum Dis. 2020; 79(6):771-777. DOI: 10.1136/annrheumdis-2019-216243. View